JP2024537288A5 - - Google Patents
Info
- Publication number
- JP2024537288A5 JP2024537288A5 JP2024521807A JP2024521807A JP2024537288A5 JP 2024537288 A5 JP2024537288 A5 JP 2024537288A5 JP 2024521807 A JP2024521807 A JP 2024521807A JP 2024521807 A JP2024521807 A JP 2024521807A JP 2024537288 A5 JP2024537288 A5 JP 2024537288A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- cell
- polypeptide construct
- attracting
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256056P | 2021-10-15 | 2021-10-15 | |
| US63/256,056 | 2021-10-15 | ||
| US202163281992P | 2021-11-22 | 2021-11-22 | |
| US63/281,992 | 2021-11-22 | ||
| PCT/EP2022/078638 WO2023062188A1 (en) | 2021-10-15 | 2022-10-14 | Subcutaneous administration of cd19-binding t cell engaging antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537288A JP2024537288A (ja) | 2024-10-10 |
| JP2024537288A5 true JP2024537288A5 (https=) | 2025-10-17 |
Family
ID=84360007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521807A Pending JP2024537288A (ja) | 2021-10-15 | 2022-10-14 | Ｃｄ１９結合ｔ細胞誘引抗体の皮下投与 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20250282864A1 (https=) |
| EP (1) | EP4415829A1 (https=) |
| JP (1) | JP2024537288A (https=) |
| KR (1) | KR20240099263A (https=) |
| AU (1) | AU2022364154A1 (https=) |
| CA (1) | CA3235228A1 (https=) |
| CL (1) | CL2024001075A1 (https=) |
| CO (1) | CO2024006099A2 (https=) |
| CR (1) | CR20240206A (https=) |
| IL (1) | IL311714A (https=) |
| JO (1) | JOP20240080A1 (https=) |
| MX (1) | MX2024004617A (https=) |
| PE (1) | PE20241619A1 (https=) |
| TW (1) | TW202332695A (https=) |
| UY (1) | UY39983A (https=) |
| WO (1) | WO2023062188A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025101672A1 (en) | 2023-11-06 | 2025-05-15 | City Of Hope | Methods comprising oncolytic viruses expressing cd19t and bispecific t cell engagers |
| TW202540166A (zh) | 2024-03-01 | 2025-10-16 | 德商安美基研究（慕尼黑）公司 | 用於治療自體免疫性疾病／自體免疫性病症的ｃｄ１９選擇性ｔ細胞接合分子 |
| WO2026072671A1 (en) | 2024-09-24 | 2026-04-02 | City Of Hope | Methods comprising oncolytic viruses expressing bcmat and bcma-targeted therapies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7112324B1 (en) | 1998-04-21 | 2006-09-26 | Micromet Ag | CD 19×CD3 specific polypeptides and uses thereof |
| JP2008501621A (ja) | 2003-05-31 | 2008-01-24 | マイクロメット アクツィエン ゲゼルシャフト | Ｂ細胞関連疾患を処置するための二重特異性抗ｃｄ３、抗ｃｄ１９抗体構築物を含む薬学的組成物 |
| RS53008B2 (sr) | 2007-04-03 | 2022-12-30 | Amgen Res Munich Gmbh | Interspecijski specifičan cd3-epsilon vezujući domen |
| KR101695327B1 (ko) | 2008-11-07 | 2017-01-11 | 암젠 리서치 (뮌헨) 게엠베하 | 급성 림프구성 백혈병의 치료방법 |
| PL2918604T3 (pl) | 2008-11-07 | 2018-05-30 | Amgen Research (Munich) Gmbh | Leczenie pediatrycznej ostrej białaczki limfoblastycznej |
| WO2016036678A1 (en) * | 2014-09-02 | 2016-03-10 | Medimmune, Llc | Formulations of bispecific antibodies |
| EA039859B1 (ru) | 2015-07-31 | 2022-03-21 | Эмджен Рисерч (Мюник) Гмбх | Биспецифические конструкты антител, связывающие egfrviii и cd3 |
| RU2651776C2 (ru) * | 2015-12-01 | 2018-04-23 | Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") | Биспецифические антитела против cd3*cd19 |
-
2022
- 2022-10-14 EP EP22805799.8A patent/EP4415829A1/en active Pending
- 2022-10-14 US US18/704,120 patent/US20250282864A1/en active Pending
- 2022-10-14 JP JP2024521807A patent/JP2024537288A/ja active Pending
- 2022-10-14 KR KR1020247015416A patent/KR20240099263A/ko active Pending
- 2022-10-14 WO PCT/EP2022/078638 patent/WO2023062188A1/en not_active Ceased
- 2022-10-14 CR CR20240206A patent/CR20240206A/es unknown
- 2022-10-14 MX MX2024004617A patent/MX2024004617A/es unknown
- 2022-10-14 PE PE2024000826A patent/PE20241619A1/es unknown
- 2022-10-14 TW TW111139062A patent/TW202332695A/zh unknown
- 2022-10-14 AU AU2022364154A patent/AU2022364154A1/en active Pending
- 2022-10-14 IL IL311714A patent/IL311714A/en unknown
- 2022-10-14 CA CA3235228A patent/CA3235228A1/en active Pending
- 2022-10-14 UY UY0001039983A patent/UY39983A/es unknown
-
2024
- 2024-04-07 JO JOJO/P/2024/0080A patent/JOP20240080A1/ar unknown
- 2024-04-11 CL CL2024001075A patent/CL2024001075A1/es unknown
- 2024-05-14 CO CONC2024/0006099A patent/CO2024006099A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024537288A5 (https=) | ||
| JP2025016606A5 (https=) | ||
| JP2023055871A5 (https=) | ||
| JP7160533B2 (ja) | 多発性骨髄腫（ｍｍ）の処置 | |
| JP2024540054A5 (https=) | ||
| TW201024310A (en) | Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine | |
| JP2024102205A5 (https=) | ||
| JP2014114288A5 (https=) | ||
| JP2009519257A5 (https=) | ||
| JP2019031567A5 (https=) | ||
| JP2016514132A5 (https=) | ||
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| JP2002544231A5 (https=) | ||
| JP2015500822A5 (https=) | ||
| JP2019532970A5 (https=) | ||
| JP2023520771A5 (https=) | ||
| EP1198251A1 (en) | Combination of an anti-ep-cam antibody with a chemotherapeutic agent | |
| JP2021523881A5 (https=) | ||
| JP2021501800A5 (https=) | ||
| TW202131950A (zh) | 依序抗ｃｄ１９療法 | |
| EP0303687A1 (en) | PREPARATIONS FOR IMPROVING ADCC THERAPIES. | |
| JP2023521853A5 (https=) | ||
| JP2023546504A5 (https=) | ||
| JP2023500480A5 (https=) | ||
| JP2002530354A (ja) | 移植の拒絶反応の出現の処置に使用するためのｃｄ２５結合分子 |